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Clinical Considerations in Orthotopic 
Liver Transplantation 
Orthotopic livcr transplantation offers an ex-
traordinary approach to end-stage liver disease 
by eliminating pathology and restoring physi-
ology to normal, rather than by the traditional 
approach of merely controlling its life-threat-
ening complications. 
Between March, 1980 and December, 1985 
500 patients, including 203 children and 297 
adults, with end-stage liver disease have been 
treated with orthotopic liver transplantation at 
the University of Colorado and the U nivcrsity 
of Pittsburgh, using cyclosporine and low-dose 
prednisone. Three hundred forty patients (68 
per cent) are surviving 1 month to 6 years after 
transplantation. 
GENERAL INDICATIONS 
Candidates for liver transplantation must 
have an irreversible disease for which conven-
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tional medical and surgical therapy have bccn 
exhausted. In most cases this is a disease of the 
liver such as chronic aggressive hepatitis or 
biliary atrcsia that leads to end-stage cirrhosis. 22 
However, liver transplantation also has been 
performed to correct inborn errors of liver 
metabolism which result mainly in pathology in 
other organ systems. 26 Two years ago the first 
successful simultaneous heart and liver trans-
plant was performed in Pittsburgh to correct a 
disorder of cholesterol metabolism in a 6-year-
old girl with severe atherosclerotic heart dis-
easc. Hl The heart transplant was necessary to 
repair the irreparable damage to the girl's heart. 
The liver transplant was necessary to corrcct 
the genetic defect responsible for the disease. 
One year ago, a 17 -year-old boy with hemophi-
lia underwent liver transplantation for chronic 
aggressive hepatitis acquired as a complication 
of factor VIII transfusions. 10 The operation re-
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stored both his liver function and coagulopathy 
to normal. Although we have not yet reached 
the point of recommending liver replacement 
for patients with this form of hemophilia, the 
risks and limitations of factor VIII replacement 
therapy are significant and such a consideration 
may be appropriate in the future. 
The timing of liver transplantation is impor-
tant. 'vVith progression of disease, the patient's 
natural resources are gradually exhausted until 
the final uncontrollable downhill course when 
the remaining liver function is inadequate to 
maintain adequate homeostasis. Transplantation 
is best performed before this last critical period. 
This allows the patient to undergo surgery while 
still an acceptable risk but avoids premature 
operation and immunosuppression. A crisis can 
be precipitated, however, during the interim 
period by conditions in which increased de-
mands are placed on the already compromised 
liver. These conditions include infection, 
trauma, hemorrhage, and dehydration. Com-
plications of liver disease may force earlier 
intervention, either because they are refi'actory 
to conventional therapy or because application 
of appropriate therapy will prevent or seriously 
interfere with the performance of orthotopic 
liver transplantation. 
PORTAL HYPERTENSION AND UPPER 
GASTROINTESTINAL BLEEDING 
Orthotopic liver transplantation provides a 
perfect trans capillary porta caval shunt through 
the new liver, and will effectively stop upper 
gastrointestinal bleeding secondary to portal 
hypertension. Temporizing measures including 
sclerotherapy and medical treatment arc useful 
until orthotopic liver transplantation can be 
performed. Shunting procedures such as por-
tosystemic and central splenorenal bypass make 
orthotopic liver transplantation much more dif-
ficult and should be avoided. Our experience 
with selective distal splenorenal shunts2 has 
been more favorable because the surgical ma-
nipulation is at a distance from the hilum. The 
condition of the portal vein is generally satisfac-
tory after distal splenorenal shunt and the 
shunt, if still patent, can usually be dealt with 
by splenectomy at the time of transplantation. 2 
Splenectomy, either in association with shunt-
ing or alone, may be harmful because it is 
associated with a Significant incidence of portal 
vein thrombosis.:2 
.. 
ASCITES 
Ascites by itself is not an indication for liver 
replacement but is an indicator of cardiovascular 
instability and advancing portal hypertenSion. 
Severe intractable ascites, often associated with 
pleural effusion, spontaneous bacterial perito-
nitis, and anasarca, clearly indicates that the 
patient has entered the final phase of end-stage 
liver disease and needs to be transplanted. 
Peritoneovenous shunts do not significantly 
complicate orthotopic liver transplantation and 
can be used when indicated. The shunt must 
be interrupted at the start of the transplant 
procedure to prevent air embolism. 
HEPATIC COMA 
Hepatic encephalopathy is an extremely se-
rious manifestation of end-stage livcr disease 
and significantly alters patient prognosis. Pa-
tients with low-grade encephalopathy often do 
well after transplantation, but the mortality of 
patients with stage IV coma is high. Neverthe-
less, a successful liver transplant can reverse all 
but the most severe degrees of hepatic enceph-
alopathy, and even patients in stage IV coma 
have completely reversed after transplantation. 
Terminal hepatic encephalopathy, manifesting 
as brain death, will not be reversed and is an 
absolute contraindication to orthotopic liver 
transplantation. 
HEPATIC RICKETS 
Hepatic rickets is frequently secn with 
chronic liver failure and is incapacitating. 25 This 
disorder is reversible after orthotopic liver 
transplantation, but if it has been allowed to 
progress to an advanced degree, rehabilitation 
is slow and difficult. We recommend that trans-
plantation be performed before advanced osteo-
porosis has set in. 
SPECIFIC INDICATIONS 
Disease entities that have been primary in-
dications for orthotopic liver transplantation are 
shown in Table 1. 
Cirrhosis, which usually is secondary to 
chronic aggressive hepatitis, is the most com-
mon indication for liver transplantation. Pa-
tients with surface and core antigen-positive 
hepatitis B are at high risk of recurrcnce after 
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Table 1. Primary Indications for Liver Transplantation 
IKDICATIOK 
Cirrhosis 
Pri mary biliary cirrhosis 
Biliary atresia 
Inborn errors of metabolism 
Sclerosing cholangitis 
Primary liver tumors 
Spcondary biliary cirrhosis 
Familial cholestasis 
Acutc hepatic necrosis 
l3uclcl-Chiari syndrome 
1\ eonatal hepatitis 
Others 
PE])lATRIC 
(N = 2(3) 
21 (10.3) 
o ( o.m 
99 (48.8) 
45 (22.2) 
2 ( 1.0) 
o 0.0) 
3 1.5) 
14 6.9) 
5 2.5) 
1 0.5) 
6 3.0) 
7 3.5) 
transplantation. The series also includes small 
numbers of patients with cryptogenic cirrhosis 
and alcoholic cirrhosis. Alcoholic cirrhosis has 
been considered historically as a poor indication 
for orthotopic liver transplantation because of 
poor patient compliance and poor patient med-
ical condition. However, there have been out-
standing exceptions and each case has to he 
examined on its individual merits. 
Biliarv atresia is the second most common 
indicati~n for liver transplantation and accounts 
for nearly 50 per cent of the pediatric cases. 3 
Portoenterostomy can be useful in allowing time 
for growth and development of infants, but most 
patients with biliary atresia will ultimately re-
quire transplantation. Multiple revisions ofpor-
toenterostomies and creation of external stomas 
can significantly complicate transplantation and 
should be avoided. 
Primary biliary cirrhosis, an idiopathic, in-
dolent disease most often affecting middle aged 
women, is the third most common indication. 
Transplantation is indicated when bilirubin be-
gins to show an increase in the rate of rise or 
exceeds 10 to 15 mg/dl, or in the prevention of 
progressive hepatic rickets. 
Inborn errors of metabolism, including Wil-
son's disease, alpha-i-antitrypsin deficiency, ty-
rosinemia, glycogen storage disease, and he-
mochromatosis, account for 13.6 per cent of the 
current series. As mentioned, hypercholester-
olemia and hemophilia also have been corrected 
by liver replacement. 10. 19 
During the past 2 years more cases of scle-
rosing cholangitis have been accepted for trans-
plantation. Many of these patients have had 
previous surgical procedures involving the he-
patic hilum. The current emphasis on percuta-
neous radiologically guided intervention should 
minimize the need for open surgical procedures 
at the hilum before transplantation. Coexisting 
ADULT 
(N = 297) 
99 (:33.3) 
83 (28.0) 
o ( 0.0) 
23 ( 9.7) 
41 (13.8) 
20 ( 6.7) 
12 ( 4.0) 
0(0.0) 
6 ( 2.0) 
7 ( 2.4) 
0(0.0) 
6 ( 2.0) 
TOTAL 
(N = .5(0) 
120 (24.0) 
83 (16.6) 
99 (19.8) 
68 (13.6) 
43 ( 8.6) 
20 ( 4.0) 
15 ( 3.m 
14 ( 2.8) 
11 ( 2.2) 
8 ( 1.6) 
6 ( 1.2) 
13 ( 2.6) 
ulcerative colitis is often burned out before 
transplantation is necessary. However, if a co-
lectomy is indicated, it is much better tolerated 
after liver transplantation rather than vice versa. 
The existence of an ileostomy during orthotopic 
liver transplantation prcdisposes to infection 
and is a major hazard. 
Secondary biliary cirrhosis can be corrected 
by orthotopic liver transplantation. These cases 
are often technically demanding because of the 
multitude of previous procedures in the hepatic 
hilum. 
Budd-Chiari syndrome can be effectively 
treated by transplantation. 12 Preoperative eval-
uation of the portal vein and inferior vena cava 
is crucial because of the high incidence of 
thrombosis in these structures. Extensive ve-
nous thrombectomy may be possible at surgery. 
After transplantation, it is essential that these 
patients be maintained on moderate anticoagu-
lation (prothrombin time 1.5 to 2 times normal). 
Primary liver tumors are considered poor 
indications for orthotopic liver transplantation 
because of a high incidence of fatal recurrence 
after transplantation. We have not considered 
metastatic liver tumors as indications for ortho-
topic liver transplantation, with the exception 
of metastatic carcinoid tumor, which has a be-
nign biologic behavior. There have been rare 
examples of orthotopic liver transplantation per-
formed by other centers for metastatic cancer. II 
Evaluation 
The preoperative evaluation must asssess ad-
visability, feasibility, and the possible need for 
multiple organ transplantation. 
Advisability. The history and physical exam-
ination remain the most accurate means of 
making this assessment in most cases. In doubt-
292 Andreas C. qzakis~et al. 
ful cases, liver volume, liver chemistries, leG 
clearance, and/or a liver biopsy may be helpful. 
Feasibility. Orthotopic liver transplantation 
may not be feasible for technical reasons or 
because of pathology involving other organs. 
Portal vein thrombosis was once considered an 
absolute contraindication to orthotopic liver 
transplantation. However, the use of venous 
grafts has allowed successful transplantation in 
some cases, but at a considerable risk. 15 Dop-
pler ultrasound is useful as a screening test for 
assessment of portal vein patency.8 In complex 
cases angiography is required. 
The clinical condition of the patient may 
necessitate a careful evaluation of the cardiores-
piratory and renal systems to determine the 
ability of the patient to tolerate the stress of 
orthotopic liver transplantation, including the 
potential nephrotoxicity of cyclosporine. Extra-
hepatic infection and metastatic disease are 
absolute contraindications to orthotopic liver 
transplantation. 
Need for Additional Organ Transplants. Or-
thotopic liver transplantation can be expected 
to have satisfactory results only if all patho-
physiology is related to liver failure. If extra-
hepatic organs are involved, a determination 
has to be made as to whether or not 1) the 
patient has enough reserve to survive the per-
ioperative period, and if not, if there are satis-
factory artificial means to sustain the patient 
and 2) the process is reversible after successful 
orthotopic liver transplantation. 
Significant experience has been acquired with 
multiple organ transplants, especially simulta-
neous liver and kidney transplantation. Many 
patients with chronic liver failure have compro-
mised renal function, either as a consequence 
of liver disease or in addition to it. The stress 
of surgery and the nephrotoxicity of cyclospor-
ine may further compromise renal function after 
transplantation. Most patients with renal dys-
function secondary to chronic liver failure can 
recover adequate renal function after liver re-
placement, but patients with intrinsic renal 
disease may not and are possible candidates for 
simultaneous transplantation. The time of the 
orthotopic liver transplantation may offer an 
"immunologic window" for a simultaneous kid-
ney transplant. It has been shown that a simul-
taneous kidney transplant may be successfully 
performed even in the face of a positive donor 
lymphocytotoxic crossmatch. 4 After orthotopic 
liver transplantation, patients may develop high 
antibody titers and later it may be difficult to 
find a biocompatible kidney allograft. Demon-
stration of irreversible pathology (polycystic, 
, 
small, or shrunken kidneys), or knowledge that 
the kidneys were normal before the liver de-
compensated facilitate decision making. The 
remaining cases require skillful clinical judg-
ment; objective criteria are being developed as 
experience grows. 
THE TRANSPLANT COMMITTEE 
After the evaluation is completed, the can-
didates are presented to a transplantation com-
mittee including surgeons, hepatologists, 
nurses, social service personnel, and immuno-
pathologists. The committee makes the final 
decision to activate the patient on the transplant 
waiting list and makes an assessment of priority. 
DONOR MATCHING 
When a liver donor becomes available, he or 
she has to be matched for liver size and ABO 
blood group with a recipient. Orthotopic liver 
transplantation across ABO blood groups can be 
done without risk of hyperacute rejection and 
with good graft survival. 5 However, graft sur-
vival for ABO identical grafts is better than that 
for ABO compatible but nonidentical or ABO 
incompatible grafts. We therefore limit ABO 
nonidentical or incompatible grafts to patients 
such as small children for whom the supply of 
available donors is severely limited or for pa-
tients in urgent need of transplantation or re-
transplantation. 
Size discrepancies are more problematic. 
Generally speaking a small liver can be fitted 
into a larger cavity, but the reverse adjustment 
is difficult. Successful transplantations have 
been performed after resection of parts of a 
graft,1 but this is done at the risk of additional 
complications and has only been used as a 
measure of last resort. 
Selection of recipients of appropriate blood 
group and size to receive a liver graft is done 
using a point system which is based mainly on 
urgency of need, logistic considerations such as 
transportation requirements, and waiting time. 
HLA matching cannot be performed prospec-
tively due to the time requirements of currently 
available techniques of liver preservation, and 
antibody crossmatching is unnecessary. 
TRANSPLANTATION 
Once the donor team is ready to be dis-
patched to obtain the graft, a recipient team is 
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Figure 1. Methods of arterial re-
construction with a single hepatic 
arterial supply. A, Conventional ar-
terial reconstruction by anastomosis 
of the donor hepatic artery to the 
recipient hepatic artery. The recipi-
A 
ent gastroduodenal artery (not 
shown) has been divided. B, Alter- B 
native method of arterial reconstruc-
tion when recipient hepatic artery 
cannot be used. An arterial homo-
graft from the infrarenal aorta is tun-
neled under the pancreas and duo-
denum and anastomosed to the 
donor hepatic artery. 
organized and anesthesia staff, the operating 
room personnel, the blood bank, and the inten-
sive care unit are immediately notified. It is 
essential that the donor team maintain com-
munication with the recipient team in order to 
coordinate the process of procurement and im-
plantation. 
The donor and recipient procedures have 
been described elsewherel8• 21 in detail and only 
a few points of particular interest will be men-
tioned here. The arterial blood supply to the 
liver is quite variable. A single hepatic artery 
originating from the celiac axis is only found 
about half the time. Left lateral segment 
branches from the left gastric artery and right 
lobar arteries from the superior mesenteric ar-
tery are common. Great care must be taken 
during procurement to preserve variant arter-
SPL 
ies. Aortoiliac allografts are taken from the 
donor for use in complicated reconstructions. 
The recipient procedure consists of four 
stages: hepatectomy, revascularization, hemo-
stasis, and biliary reconstruction. A major de-
velopment in the recipient procedure has been 
the use of a venovenous bypass. 7 This procedure 
facilitates hepatectomy and maintains cardiovas-
cular stability during the anhepatic phase of 
surgery.17 The use of vascular grafts permits 
rearterialization of the allograft in complicated 
cases. 16 Iliac grafts routinely harvested from the 
donor can be used as aortohepatic grafts, be-
tween the recipient infrarenal aorta and the 
donor hepatic artery, if the recipient hepatic 
artery is inadequate (Fig. lA and B). If the 
donor organ has a double arterial supply from 
the celiac axis and superior mesenteric artery, 
294 Andreas C. Tzakis.et al. 
c 
B 
o 
l 
II! dau~Ibo ~
Figure 2. \lpthods of arterial reconstruction with complex hepatic arterial supply. A, A dual arterial sllpph to the liver 
with left hpl'atic artery originating from the celiac axis (CAl and right hepatic arlen originating from the superior mesenteric 
artery Ep~fAF is preserved hy resecting an aortic patch containing the origins of hoth CA and S\,1A. A segment proximal to 
the S1\IA, including the origin of the right hepatic artery, must also be preserved. B, The aortic patch is folded over to 
anastomose the origin of the CA to the SMA. The SMA distal to the origin of the right hepatic artery is then used for 
anastomosis to the donor hepatic artery. C, An altcrnative method of reconstruction using an interposition graft of donor 
SMA containing the origin of the right hepatic artery hetween the donor left hepatic and recipient common hepatic arteries. 
D, Use of a homograft from the inti-arenal aorta in combinatioll with the reconstruction in C when there is no suitable 
recipient hepatic artery available ["r anastomosis. 
the origin of the celiac axis and superior mes-
enteric artery are sewn together using a fold-
over Carrel patch technique. 6 The distal end of 
the superior mesenteric artery is then used as 
the point of anastomosis to the recipient (Fig. 
2). Venous grafts (donor vcna cava or iliac vein) 
can be use~l to replace a fibrotic or caverno-
matous recipient portal vein15 or to add length 
to short vena cava cuffs. Whenever possible, 
the biliary tract is reconstructed by a duct to 
duct anastomosis over a T -tubc stcnt. 18.21 If this 
is not possible, the preferred anastomosis is a 
choledochojejullostomy with an internal stent 
to a Roux-ell-Y jejunal lim h (Fig .. 3).18,21 
POSTOPERATIVE COURSE 
The stage for the postoperative course is set 
by the preoperative status of the recipient, the 
quality of the donor organ, and the course of 
the recipient operation. Immunologic reactions 
and opportunistic infections can alter the proc-
ess. 
Potential technical complications arc numer-
ous. The most frC(lUent are arterial thrombosis 
and biliary complications. Hepatic artery 
throm bosis is a potentially fatal complication 
which is much more frequent in children than 
in adults (10.4 versus 3.4 pcr cent).24 It may 
result in gangrene of the liver or irreparable 
complications of ischemic necrosis of the donor 
bile duct. An occasional patient has survived 
without retransplantation because of the devel-
opment of sufficient collateral arterial circula-
tion. An anticoagulation protocol iuvolYing the 
use of low molecular weight dextrall, low-dose 
heparin, and aspirin is cu~rently under investi-
gation. Early results indicate that this regimen 
may be effective in lowering the incidence of 
hepatic artcry thrombosis. 
Biliary complications, once called the 
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A 
Figure 3. Biliary tract reconstruction. A, 
Direct duct to duct repair over aT-tube B 
brought out through a stab incision in the 
recipient common duct contralateral to 
ne<lrbv vasclllar an<lstomoses. B, Biliarv re-
constt:llction bv end-to-side anastomo;is of 
the donor C'(lI1{moll bile duct to an 18 inch 
HOllX-ell-l limh of proximal jejunum. A 
polyethylene inLmt feeding tube is used as 
an internal stcnt. 
Achilles' heel of orthotopic liver transplantation, 
occurred in 52 (16.6 per cent) of313 consecutive 
cases recently reviewed by Lerut et a1. 9 The 
prognosis of patients with biliary tract compli-
cations has improved because earlier detection 
is possible with the current radiologic tech-
niques. Ultrasound, CT scans, and T-tube cho-
langiograms are common baseline studies. Per-
cutaneous cholangiograms and arteriograms are 
ohtained when indicated. Primary biliary tract 
Lig. of 
Treitz 
complications must be differentiated from bile 
leaks secondary to hepatic artery thrombosis. 
The immunologic reactions after liver trans-
plantation include rejection (acute and chronic) 
and graft versus host reactions. Acute or cellular 
rejection has protean manifestations, but under 
cyclosporine and prednisone usually presents 
with malaise, fever, and changes in the quality 
and quantity of bile. The diagnosis can be 
further suspected by an elevation of the serum 
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bilirubin and hepatic transaminases and can be 
confirmed with a percutaneous livcr biopsy. 
Cyclosporinc in combination with low-dose ste-
roids is to date the most efIective known means 
of preventing rejection. Stcroid boluses have 
been the preferred treatment of acute rejection. 
During the past 2 years, a new form of antilym-
phocyte antibody therapy, OKT-3 monoclonal 
antibody, has been uscd with satisfactory re-
sults. 20 
The use of these agents requires a great deal 
of clinical judgment: insufficient use will result 
in graft loss due to rejection; overusage will 
result in opportunistic infections, which can be 
fatal. The matter is further complicated at times 
by the coexistence of rejection and opportunis-
tic infection. 
Lymphoproliferative disorders are consid-
ered manifestations of overilllmunosuppression, 
especially with eyclosporine. 2:3 They usually will 
regress with reduction or withdrawal of immu-
nosuppression. 
Chronic rejection is a much more insidious 
process, which manifests as bilc duct disap-
pearance and fibrosis, is refractory to therapy, 
and requires retransplantation. The graft versus 
host reaction usually occurs in orthotopic liver 
transplantations across the ABO blood barrier, 
and usually presents as a combination of he-
molytic anemia, fever, and thrombocytopenia, 
usually 2 to 3 weeks after operation. 13 Gastroin-
testinal symptoms are not unusual, but pneu-
monitis or severe rash is uncommon. It is 
usually a self-limiting syndrome and requires 
only supportive treatment. 
RESULTS 
Three hundred forty (68 per cent) of the 500 
patients transplanted with cyelosporine and 
prednisone are alive, including 197 (66.3 per 
cent) of the adults and 143 (70.4 per cent) of 
the children. 
The goal of orthotopic liver transplantation is 
restoration of a normal life, and this is achieved 
in the vast majority of successful orthotopic 
liver transplantation recipients. Eighty-one 
long-term survivors transplanted with cyc1o-
sporine-prednisone were reviewed by Shaw et 
al. 14 Only seven of these patients were disabled, 
and two additional patients were unemployed. 
The remainder were fully employed, active 
homemakers, or attending school. As the results 
of orthotopic liver transplantation are continu-
ously improving, we are seeing increasing num-
bers of successful orthotopic liver transplant 
.. 
recipients among the productive individuals of 
our society. 
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